Histamine regulation in glucose and lipid metabolism via histamine receptors: Model for nonalcoholic steatohepatitis in mice

American Journal of Pathology

Volumn 177, Issue 2, 2010, Pages 713-723

  Wang, Ke Yong ^a   Tanimoto, Akihide ^a,b   Yamada, Sohsuke ^a   Guo, Xin ^a   Ding, Yan ^a   Watanabe, Teruo ^c   Watanabe, Takeshi ^d   Kohno, Kimitoshi ^a   Hirano, Ken Ichi ^e   Tsukada, Hideo ^f   Sasaguri, Yasuyuki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c FUKUOKA WAJIRO HOSPITAL   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f CENTRAL RESEARCH LABORATORY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CHOLESTEROL; FLUORODEOXYGLUCOSE F 18; GLUCOSE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; LEPTIN; LIVER ENZYME; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL DIET; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME BLOOD LEVEL; FAT INTAKE; GLUCOSE BRAIN LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HYPERLEPTINEMIA; HYPERLIPIDEMIA; HYPOADIPONECTINEMIA; INFLAMMATION; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIPID DIET; LIPID METABOLISM; LIVER INJURY; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; WILD TYPE;

EID: 77957254037     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.091198     Document Type: Article

References (60)

1. Higuchi S, Tanimoto A, Arima N, Xu H, Murata Y, Hamada T, Makishima K, Sasaguri Y: Effects of histamine and interleukin-4 synthesized in arterial intima on phagocytosis by monocytes/macrophages in relation to atherosclerosis. FEBS Lett 2001, 505:217-222
2. Matsuki Y, Tanimoto A, Hamada T, Sasaguri Y: Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma. Mod Pathol 2003, 16:72-78
3. Tanimoto A, Matsuki Y, Tomita T, Sasaguri T, Shimajiri S, Sasaguri Y: Histidine decarboxylase expression in pancreatic endocrine cells and related tumors. Pathol Int 2004, 54:408-412
4. Bakker RA, Timmerman H, Leurs R: Histamine receptors: specific ligands, receptor biochemistry, and signal transduction. Clin Allergy Immunol 2002, 17:27-64
5. Ohtsu H, Watanabe T: New functions of histamine found in histidine decarboxylase gene knockout mice. Biochem Biophys Res Commun 2003, 305:443-447
6. Fülöp AK, Földes A, Buzás E, Hegyi K, Miklós IH, Romics L, Kleiber M, Nagy A, Falus A, Kovacs KJ: Hyperleptinemia, visceral adiposity, and decreased glucose tolerance in mice with a targeted disruption of the histidine decarboxylase gene. Endocrinology 2003, 144:4306-4314
7. Masaki T, Yoshimatsu H, Chiba S, Watanabe T, Sakata T: Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice. Diabetes 2001, 50:385-391
8. Takahashi K, Suwa H, Ishikawa T, Kotani H: Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype. J Clin Invest 2002, 110:1791-1799
9. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. J Am Med Assoc 2002, 288:2709-2716
10. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988-1994. Arch Intern Med 2003, 163:427-436
11. Neuschwander-Tetri BA: Nonalcoholic steatohepatitis and the metabolic syndrome. Am J Med Sci 2005, 330:326-335
12. Agarwal N, Sharma BC: Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH). Hepatol Res 2005, 33:92-96
13. Washington K, Wright K, Shyr Y, Hunter EB, Olson S, Raiford DS: Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver. Hum Pathol 2000, 31:822-828
14. Leclercq IA, Farrell GC, Schriemer R, Robertson GR: Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol 2002, 37:206-213
15. Sahai A, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM, Whitington PF: Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol 2004, 287:G1032-G1043
16. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K: cDNA cloning and expression of a novel adipose specific collagen-like factor apM1 (AdiPose most abundant gene transcript 1). Biochem Biophys Res Commun 1996, 221:286-289
17. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995, 270:26746-26749
18. Marchesini G, Marzocchi R, Agostini F, Bugianesi E: Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 2005, 16:421-427
19. Vuppalanchi R, Marri S, Kolwankar D, Considine RV, Chalasani N: Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study. J Clin Gastroenterol 2005, 39:237-242
20. Inoue I, Yanai K, Kitamura D, Taniuchi I, Kobayashi T, Niimura K, Watanabe T: Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. Proc Natl Acad Sci USA 1996, 93:13316-13320
21. Kobayashi T, Tonai S, Ishihara Y, Koga R, Okabe S, Watanabe T: Abnormal functional and morphological regulation of the gastric mucosa in histamine H2 receptor-deficient mice. J Clin Invest 2000, 105:1741-1749
22. 19F-NMR spectroscopy. Int J Rad Appl Instrum A Isot 1986, 37:695-701
23. Uchida H, Okamoto T, Ohmura T, Shimizu K, Satoh N, Koike T, Yamashita T: A compact planar positron imaging system. Nucl Instr Meth 2004, A516:564-574
24. Sasaguri Y, Wang KY, Tanimoto A, Tsutsui M, Ueno H, Murata Y, Kohno Y, Yamada S, Ohtsu H: Role of histamine produced by bone marrow-derived vascular cells in pathogenesis of atherosclerosis. Circ Res 2005, 96:974-981
25. Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226:497-509
26. Anstee QM, Goldin RD: Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 2006, 87:1-16
27. Schmitz-Peiffer C: Signaling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal 2000, 12:583-594
28. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cuhman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, Shulman GI: Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002, 277:50230-50236
29. Dube JJ, Bhatt BA, Dedousis N, Bonen A, O'Doherty RM: Leptin, skeletal muscle lipids, and lipid-induced insulin resistance. Am J Physiol Regul Integr Comp Physiol 2007, 293:R642-R650
30. Ebihara K, Ogawa Y, Masuzaki H, Shintani M, Miyanaga F, Aizawa-Abe M, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Gavrilova O, Reitman ML, Nakao K: Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes 2001, 50:1440-1448
31. Yoshimatsu H, Itateyama E, Kondou S, Tajima D, Himeno K, Hidaka S, Kurokawa M, Sakata T: Hypothalamic neuronal histamine as a target of leptin in feeding behavior. Diabetes 1999, 48:2286-2291
32. German J, Kim F, Schwartz GJ, Havel PJ, Rhodes CJ, Schwartz MW, Morton GJ: Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. Endocrinology 2009, 150:4502-4511
33. Zhou YT, Shimabukuro M, Koyama K, Lee Y, Wang MY, Trieu F, Newgard CB, Unger RH: Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. Proc Natl Acad Sci USA 1997, 94:6386-6390
34. Cusin I, Zakrzewska KE, Boss O, Muzzin P, Giacobino JP, Ricquier D, Jeanrenaud B, Rohner-Jeanrenaud F: Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins. Diabetes 1998, 47:1014-1019
35. Masaki T, Chiba S, Yasuda T, Noguchi H, Kakuma T, Watanabe T, Sakata T, Yoshimatus H: Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity. Diabetes 2004, 53:2250-2260
36. Poitout V, Rouault C, Guerre-Millo M, Reach G: Does leptin regulate insulin secretion? Diabetes Metab 1998, 24:321-326
37. Kieffer TJ, Habener JF: The adipoinsulin axis: effects of leptin on pancreatic β cells. Am J Physiol Endocrinol Metab 2000, 278:E1-E14
38. Kulkarni RN, Wang ZL, Wang RM, Hurley JD, Smith DM, Ghatei MA, Withers DJ, Gardiner JV, Bailey CJ, Bloom SR: Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest 1997, 100:2729-2736
39. Bock T, Pakkenberg B, Buschard K: Increased islet volume but unchanged islet number in ob/ob mice. Diabetes 2003, 52:1716-1722
40. Baetens D, Stefan Y, Ravazzola M, Malaisse-Lagae F, Coleman DL, Alteration of islet cell populations in spontaneously diabetic mice. Diabetes 1978, 27:1-7
41. Morioka T, Asilmaz E, Hu J, Dishinger JF, Kurpad AJ, Elias CF, Li H, Elmquist JK, Kennedy RT, Kulkarni RN: Disruption of leptin receptor expression in the pancreas directly affects β cell growth and function in mice. J Clin Invest 2007, 117:2860-2868
42. Sjöholm A: Histaminergic regulation of pancreatic β cell replication and insulin secretion. Biochem Biophys Res Commun 1995, 214:224-229
43. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y, Funahashi T: Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004, 68:975-981
44. Okamoto Y, Kihara S, Funahashi T, Matsuzawa Y, Libby P: Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci 2006, 110:267-278
45. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002, 8:1288-1295
46. Nawrocki AR, Rajala MW, Tomas E, Pajvani UB, Saha AK, Trumbauer ME, Pang Z, Chen AS, Ruderman NB, Chen H, Rossetti L, Scherer PE: Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor γ agonists. J Biol Chem 2006, 281:2654-2660
47. Benomar Y, Naour N, Aubourg A, Bailleux V, Gertler A, Djiane J, Guerre-Millo M, Taouis M: Insulin and leptin induce Glut4 plasma membrane translocation and glucose uptake in a human neuronal cell line by a phosphatidylinositol 3-kinase-dependent mechanism. Endocrinology 2006, 147:2550-2556
48. Choeiri C, Staines W, Messier C: Immunohistochemical localization and quantification of glucose transporters in the mouse brain. Neuroscience 2002, 111:19-34
49. Peters A, Schweiger U, Frühwald-Schultes B, Born J, Fehm HL: The neuroendocrine contral of glucose allocation. Exp Clin Endocrinol Diabetes 2002, 110:199-211
50. Peters A, Schweiger U, Pellerin L, Hubold C, Oltmanns KM, Conrad M, Schultes B, Born J, Fehm HL: The selfish brain: competition for energy resources. Neurosci Biobehav Rev 2004, 28:143-180
51. Kamada Y, Tamura S, Kiso S, Matsumoto H, Saji Y, Yoshida Y, Fukui K, Maeda N, Nishizawa H, Nagaretani H, Okamoto Y, Kihara S, Miyagawa J, Shinomura Y, Funahashi T, Matsuzawa T: Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 2003, 125:1796-1807
52. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7:941-946
53. Awazawa M, Ueki K, Inabe K, Yamauchi T, Kaneko K, Okazaki Y, Bardeesy N, Ohnishi S, Nagai R, Kadowaki T: Adiponectin suppresses hepatic SREBP-1c expression in an AdipoR1/LKB1/AMPK dependent pathway. Biochem Biophys Res Commun 2009, 382:51-56
54. Tomita K, Oike Y, Teratani T, Taguchi T, Noguchi M, Suzuki T, Mizutani A, Yokoyama H, Irie R, Sumimtoto H, Takayanagi A, Miyashita K, Akao M, Tabata M, Tamiya G, Ohkura T, Hibi T: Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. Hepatology 2008, 48:458-473
55. Day CP, James OF: Steatohepatitis: a tale of two "hits"? Gatroenterology 1998, 114:842-845
56. Matsuzawa N, Takamura T, Kurita S, Misu H, Ota T, Ando H, Yokoyama M, Honda M, Zen Y, Nakanuma Y, Miyamoto K, Kaneko S: Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 2007, 46:1392-1403
57. Caballero F, Fernandez A, De Lacy AM, Fernandez-Checa JC, Caballeria J, Garcia-Ruiz C: Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. J Hepatol 2009, 50:789-796
58. Mari M, Caballero F, Collel A, Morales A, Caballeria J, Fernandez A, Enrich C, Fernandez-Checa JC, Garcia-Ruiz C: Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab 2006, 4:185-189
59. Wouters K, Van Gorp PJ, Bieghs V, Gijbels MJ, Duimel H, Lütjohann D, Kerksiek A, Van Kruchten R, Maeda N, Staels B, Van Bilsen M, Shiri-Sverdlov R, Hofker MH: Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 2008, 48:474-486
60. Andrade RJ, Lucena MI, Martin-Vivaldi R, Fernandez MC, Nogueras F, Pelaez G, Gomez-Outes A, Garcia-Escano MD, Bellot V, Hervas A, Cardenas F, Bermudez F, Romero M, Salmeron J: Acute liver injury associated with the use of ebrotidine, a new H2-receptor antagonist. J Hepatol 1999, 31:641-646